Contact
Please use this form to send email to PR contact of this press release:
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to Direct TCR-T Cell Therapy Program
TO:
Please use this form to send email to PR contact of this press release:
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to Direct TCR-T Cell Therapy Program
TO: